133 related articles for article (PubMed ID: 14504197)
1. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
Adami HO; Kuper H; Andersson SO; Bergström R; Dillner J
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):872-5. PubMed ID: 14504197
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2952-5. PubMed ID: 16365015
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
Karagas MR; Nelson HH; Sehr P; Waterboer T; Stukel TA; Andrew A; Green AC; Bavinck JN; Perry A; Spencer S; Rees JR; Mott LA; Pawlita M
J Natl Cancer Inst; 2006 Mar; 98(6):389-95. PubMed ID: 16537831
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.
Pintos J; Black MJ; Sadeghi N; Ghadirian P; Zeitouni AG; Viscidi RP; Herrero R; Coutlée F; Franco EL
Oral Oncol; 2008 Mar; 44(3):242-50. PubMed ID: 17467327
[TBL] [Abstract][Full Text] [Related]
6. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.
Rosenblatt KA; Carter JJ; Iwasaki LM; Galloway DA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):763-8. PubMed ID: 12917208
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
Masini C; Fuchs PG; Gabrielli F; Stark S; Sera F; Ploner M; Melchi CF; Primavera G; Pirchio G; Picconi O; Petasecca P; Cattaruzza MS; Pfister HJ; Abeni D
Arch Dermatol; 2003 Jul; 139(7):890-4. PubMed ID: 12873884
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
9. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
11. Correlates of the spread of human papillomavirus infection.
Silins I; Kallings I; Dillner J
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):953-9. PubMed ID: 11008914
[TBL] [Abstract][Full Text] [Related]
12. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
13. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
14. Demographic and risk factors in patients with head and neck tumors.
Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
[TBL] [Abstract][Full Text] [Related]
15. The role of human papillomavirus infection in prostate cancer.
Al-Maghrabi JA
Saudi Med J; 2007 Mar; 28(3):326-33. PubMed ID: 17334454
[TBL] [Abstract][Full Text] [Related]
16. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
[TBL] [Abstract][Full Text] [Related]
17. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile.
Ferreccio C; Prado RB; Luzoro AV; Ampuero SL; Snijders PJ; Meijer CJ; Vaccarella SV; Jara AT; Puschel KI; Robles SC; Herrero R; Franceschi SF; Ojeda JM
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2271-6. PubMed ID: 15598792
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
20. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
